AYU (An International Quarterly Journal of Research in Ayurveda)

CLINICAL RESEARCH
Year
: 2010  |  Volume : 31  |  Issue : 2  |  Page : 197--204

A short-term intervention trial on HIV positive patients using a Sri Lankan classical rasayana drug - Ranahamsa Rasayanaya


K.I.W.K Somarathna1, HM Chandola1, B Ravishankar2, KN Pandya3, A.M.P Attanayake4 
1 Department of Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India
2 Department of Pharmacology Laboratory, I.P.G.T.& R.A., Jamnagar,Gujarat,India
3 Department of Medicine, Infectious Disease Ward, M.P. Shah Medical College, Jamnagar,Gujarat,India
4 Department of Medicine, M.P.I.Y.N.E.R., Gujarat Ayurved University, Jamnagar, Gujarat, India

Correspondence Address:
K.I.W.K Somarathna
Lecturer, Department of Kayachikitsa, Institute of Indigenous Medicine, University of Colombo, Rajgiriya, Sri Lanka

Rational use of Rasayana therapy, in the management of HIV infected individuals, could potentially stabilize the destructive control mechanisms, by modulating the psycho-neuro-endocrine-immune axis. The objective of the present study has been to determine the short-term effects of Ranahamsa Rasayanaya (RR) in HIV infected patients. A total of 27 patients with documented HIV infection were randomly assigned to two groups, Group A - 5 g of RR twice daily with cow«SQ»s milk and sugar. Group B - Only routine modern therapy was continued, if any they were taking, including highly active anti-retroviral therapy (HAART). Absolute CD4 + T-cell and total lymphocyte counts were measured in these patients, registered under Group A. Only 21 participants completed the study protocol (In Group A, 15 patients and in Group B, 6 patients). Initial mean CD4 + T-cell count was 304.50 ± 43.36 cells/microliter, which increased to 430.44 ± 66.01 cells/microliter by 41.36% (P<0.05), measured among 9 patients out of 15, who received RR in Group A. The RR seemed to be a safer adjuvant in people with HIV infection with respect to absolute CD4 + T-cell count over a 90 days treatment.


How to cite this article:
Somarathna K, Chandola H M, Ravishankar B, Pandya K N, Attanayake A. A short-term intervention trial on HIV positive patients using a Sri Lankan classical rasayana drug - Ranahamsa Rasayanaya.AYU 2010;31:197-204


How to cite this URL:
Somarathna K, Chandola H M, Ravishankar B, Pandya K N, Attanayake A. A short-term intervention trial on HIV positive patients using a Sri Lankan classical rasayana drug - Ranahamsa Rasayanaya. AYU [serial online] 2010 [cited 2021 Dec 2 ];31:197-204
Available from: https://www.ayujournal.org/article.asp?issn=0974-8520;year=2010;volume=31;issue=2;spage=197;epage=204;aulast=Somarathna;type=0